Presentation
Presentation BCHM 163
Rating
Sold
-
Pages
6
Uploaded on
02-03-2023
Written in
2022/2023
XL-765 is a small molecule inhibitor of phosphoinositide 3-kinase (PI3K) and mTOR (mammalian target of rapamycin) signaling pathways. These pathways are often overactive in cancer cells, making them attractive targets for cancer therapy.
Show more
Read less
Institution
Hofstra University
Course
BCHM 163
Whoops! We can’t load your doc right now. Try again or contact support.
Written for
- Institution
-
Hofstra University
- Course
-
BCHM 163
Document information
- Uploaded on
- March 2, 2023
- Number of pages
- 6
- Written in
- 2022/2023
- Type
- Presentation
- Person
- Unknown
Subjects
-
xl 765cancer drug metabolism
$20.49
Get access to the full document:
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
Get to know the seller
navmg19
Also available in package deal
Package deal
XL-765
2
2023
$ 40.98
More info